Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001104659-12-057933)

Filing Details

Accession Number:: 0001104659-12-057933
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-08-14 18:52:31
Reporting Period:: 2012-08-13

Filing Date:: 2012-08-14
Accepted Time:: 2012-08-14 18:52:31
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
881524	Vivus Inc	VVUS	Pharmaceutical Preparations (2834)	943136179

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1220354	B Mark Logan	1172 Castro Street Mountain View CA 94040		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-08-13	18,184	$4.25	71,184	No	4	M	Direct
Common Stock	Disposition	2012-08-13	18,184	$21.81	53,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Non-Qualified Stock Option (right to buy)	Disposition	2012-08-13	18,184	$0.00	18,184	$4.25

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
11,816		2017-01-29	No	4	M	Direct

Footnotes

The sale price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold ranging from $21.80 to $21.82 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
The option is fully vested and immediately exercisable.